MedTrace Logo

Immunising Mums Against Pertussis 3

NCT03578120 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 64

Last updated 2022-04-11

No results posted yet for this study

Summary

This study will aim to recruit at least 70 children who participated in the iMAP2 study whose mothers received a pertussis vaccine in pregnancy as part of the iMAP2 trial and at least 15 children born to mothers who did not receive a pertussis vaccine in pregnancy. Blood samples will be obtained prior to and one month after the routine preschool booster vaccination and vaccine responses compared between children whose mothers received one of two pertussis vaccines or no pertussis vaccine in pregnancy. Children will be vaccinated with the routine booster vaccines by the study team on the same visit as the pre-vaccination bloods are taken.

Conditions

Interventions

BIOLOGICAL

Pre-school booster vaccine

Routine vaccination with pre-school booster vaccine

Sponsors & Collaborators

  • University of Oxford

    collaborator OTHER

  • University Hospitals Bristol and Weston NHS Foundation Trust

    collaborator OTHER

  • St George's, University of London

    lead OTHER

Principal Investigators

  • Paul T Heath, MBBS FRCPCH · St George's, University of London

Eligibility

Min Age
3 Years
Max Age
4 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-24
Primary Completion
2020-03-01
Completion
2020-03-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03578120 on ClinicalTrials.gov